🇪🇺 MMR vaccine in European Union

EMA authorised MMR vaccine on 5 May 2006

Marketing authorisation

EMA — authorised 5 May 2006

  • Application: EMEA/H/C/000604
  • Marketing authorisation holder: Merck Sharp & Dohme B.V.
  • Local brand name: M-M-RVaxPro
  • Indication: M-M-RVaxPro is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months or older. For use in measles outbreaks, or for post-exposure vaccination, or for use in previously unvaccinated children older than 12 months who are in contact with susceptible pregnant women, and persons likely to be susceptible to mumps and rubella.
  • Status: approved

Read official source →

Other Immunology / Infectious Disease approved in European Union

Frequently asked questions

Is MMR vaccine approved in European Union?

Yes. EMA authorised it on 5 May 2006.

Who is the marketing authorisation holder for MMR vaccine in European Union?

Merck Sharp & Dohme B.V. holds the EU marketing authorisation.